204 related articles for article (PubMed ID: 11306917)
21. A mutant mouse with a highly specific contextual fear-conditioning deficit found in an N-ethyl-N-nitrosourea (ENU) mutagenesis screen.
Reijmers LG; Coats JK; Pletcher MT; Wiltshire T; Tarantino LM; Mayford M
Learn Mem; 2006; 13(2):143-9. PubMed ID: 16585790
[TBL] [Abstract][Full Text] [Related]
22. Optimal N-ethyl-N-nitrosourea (ENU) doses for inbred mouse strains.
Weber JS; Salinger A; Justice MJ
Genesis; 2000 Apr; 26(4):230-3. PubMed ID: 10748459
[TBL] [Abstract][Full Text] [Related]
23. An ENU-induced mutation in Rs1h causes disruption of retinal structure and function.
Jablonski MM; Dalke C; Wang X; Lu L; Manly KF; Pretsch W; Favor J; Pardue MT; Rinchik EM; Williams RW; Goldowitz D; Graw J
Mol Vis; 2005 Jul; 11():569-81. PubMed ID: 16088326
[TBL] [Abstract][Full Text] [Related]
24. N-ethyl-N-nitrosourea-based generation of mouse models for mutant G protein-coupled receptors.
Grosse J; Tarnow P; Römpler H; Schneider B; Sedlmeier R; Huffstadt U; Korthaus D; Nehls M; Wattler S; Schöneberg T; Biebermann H; Augustin M
Physiol Genomics; 2006 Aug; 26(3):209-17. PubMed ID: 16720677
[TBL] [Abstract][Full Text] [Related]
25. Mutagenesis as an unbiased approach to identify novel contraceptive targets.
Handel MA; Lessard C; Reinholdt L; Schimenti J; Eppig JJ
Mol Cell Endocrinol; 2006 May; 250(1-2):201-5. PubMed ID: 16412559
[TBL] [Abstract][Full Text] [Related]
26. Neurobehavioral mutants identified in an ENU-mutagenesis project.
Cook MN; Dunning JP; Wiley RG; Chesler EJ; Johnson DK; Miller DR; Goldowitz D
Mamm Genome; 2007 Aug; 18(8):559-72. PubMed ID: 17629744
[TBL] [Abstract][Full Text] [Related]
27. Optimizing screening and mating strategies for phenotype-driven recessive N-ethyl-N-nitrosourea screens in mice.
Barbaric I; Dear TN
J Am Assoc Lab Anim Sci; 2007 Nov; 46(6):44-9. PubMed ID: 17994672
[TBL] [Abstract][Full Text] [Related]
28. [Characterization of ENU-mutant mice. Animal models for human diseases using morphological and molecular methods].
Wagner S; Calzada-Wack J; Rosemann M; Becker L; Tost M; Silva-Buttkus P; Klein-Rodewald T; Fuchs H; Neff F; Hrabé de Angelis M; Esposito I
Pathologe; 2010 Oct; 31 Suppl 2():147-52. PubMed ID: 20835709
[TBL] [Abstract][Full Text] [Related]
29. ENU mutagenesis and the search for deafness genes.
Hardisty RE; Mburu P; Brown SD
Br J Audiol; 1999 Oct; 33(5):279-83. PubMed ID: 10890141
[TBL] [Abstract][Full Text] [Related]
30. ENU mutagenesis as a tool for understanding lung development and disease.
Yates L; McMurray F; Zhang Y; Greenfield A; Moffatt M; Cookson W; Dean C
Biochem Soc Trans; 2009 Aug; 37(Pt 4):838-42. PubMed ID: 19614604
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis.
Furuse T; Wada Y; Hattori K; Yamada I; Kushida T; Shibukawa Y; Masuya H; Kaneda H; Miura I; Seno N; Kanda T; Hirose R; Toki S; Nakanishi K; Kobayashi K; Sezutsu H; Gondo Y; Noda T; Yuasa S; Wakana S
Eur J Neurosci; 2010 Apr; 31(7):1281-91. PubMed ID: 20345915
[TBL] [Abstract][Full Text] [Related]
32. Mouse mutagenesis with the chemical supermutagen ENU.
Probst FJ; Justice MJ
Methods Enzymol; 2010; 477():297-312. PubMed ID: 20699147
[TBL] [Abstract][Full Text] [Related]
33. Mouse models of genetic disease: new approaches, new paradigms.
Brown SD
J Inherit Metab Dis; 1998 Aug; 21(5):532-9. PubMed ID: 9728333
[TBL] [Abstract][Full Text] [Related]
34. Screen for alterations of iron related parameters in N-ethyl-N-nitrosourea-treated mice identified mutant lines with increased plasma ferritin levels.
Rathkolb B; Klempt M; Sabrautzki S; Michel D; Klaften M; Laufs J; Sedlmeier R; Hans W; Fuchs H; Muckenthaler MU; Horsch M; Campagna DR; Fleming M; Hrabé de Angelis M; Wolf E; Aigner B
Biometals; 2015 Apr; 28(2):293-306. PubMed ID: 25636453
[TBL] [Abstract][Full Text] [Related]
35. Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource.
Nolan PM; Peters J; Vizor L; Strivens M; Washbourne R; Hough T; Wells C; Glenister P; Thornton C; Martin J; Fisher E; Rogers D; Hagan J; Reavill C; Gray I; Wood J; Spurr N; Browne M; Rastan S; Hunter J; Brown SD
Mamm Genome; 2000 Jul; 11(7):500-6. PubMed ID: 10886012
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size.
Srivastava AK; Kapur S; Mohan S; Yu H; Kapur S; Wergedal J; Baylink DJ
J Bone Miner Res; 2005 Jun; 20(6):1041-50. PubMed ID: 15883645
[TBL] [Abstract][Full Text] [Related]
37. Linear dose-response relationship of erythrocyte enzyme-activity mutations in offspring of ethylnitrosourea-treated mice.
Charles DJ; Pretsch W
Mutat Res; 1987 Jan; 176(1):81-91. PubMed ID: 3796661
[TBL] [Abstract][Full Text] [Related]
38. ENU mutagenesis, a way forward to understand gene function.
Acevedo-Arozena A; Wells S; Potter P; Kelly M; Cox RD; Brown SD
Annu Rev Genomics Hum Genet; 2008; 9():49-69. PubMed ID: 18949851
[TBL] [Abstract][Full Text] [Related]
39. Sensitized mutagenesis screen in Factor V Leiden mice identifies thrombosis suppressor loci.
Westrick RJ; Tomberg K; Siebert AE; Zhu G; Winn ME; Dobies SL; Manning SL; Brake MA; Cleuren AC; Hobbs LM; Mishack LM; Johnston AJ; Kotnik E; Siemieniak DR; Xu J; Li JZ; Saunders TL; Ginsburg D
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9659-9664. PubMed ID: 28827327
[TBL] [Abstract][Full Text] [Related]
40. Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program.
Masuya H; Inoue M; Wada Y; Shimizu A; Nagano J; Kawai A; Inoue A; Kagami T; Hirayama T; Yamaga A; Kaneda H; Kobayashi K; Minowa O; Miura I; Gondo Y; Noda T; Wakana S; Shiroishi T
Mamm Genome; 2005 Nov; 16(11):829-37. PubMed ID: 16284798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
